CN113621601B - Sucrose isomerase mutant, coding gene and application thereof - Google Patents
Sucrose isomerase mutant, coding gene and application thereof Download PDFInfo
- Publication number
- CN113621601B CN113621601B CN202110706337.4A CN202110706337A CN113621601B CN 113621601 B CN113621601 B CN 113621601B CN 202110706337 A CN202110706337 A CN 202110706337A CN 113621601 B CN113621601 B CN 113621601B
- Authority
- CN
- China
- Prior art keywords
- sucrose
- mutant
- sucrose isomerase
- isomaltulose
- asp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010047540 sucrose isomerase Proteins 0.000 title claims abstract description 59
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 31
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims abstract description 37
- 229930006000 Sucrose Natural products 0.000 claims abstract description 34
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 31
- 239000005720 sucrose Substances 0.000 claims abstract description 31
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- 239000013598 vector Substances 0.000 claims abstract description 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 3
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000002210 biocatalytic effect Effects 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 39
- 108090000790 Enzymes Proteins 0.000 abstract description 39
- 230000000694 effects Effects 0.000 abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 238000006555 catalytic reaction Methods 0.000 abstract description 5
- 241000282326 Felis catus Species 0.000 abstract description 4
- 230000003197 catalytic effect Effects 0.000 abstract description 3
- 238000012933 kinetic analysis Methods 0.000 abstract description 2
- 229960004793 sucrose Drugs 0.000 description 29
- 241000588724 Escherichia coli Species 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 17
- 239000007788 liquid Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 12
- 230000035772 mutation Effects 0.000 description 11
- 239000013612 plasmid Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241000588748 Klebsiella Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UGIBTKGQVWFTGX-BIIVOSGPSA-N Asp-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N)C(=O)O UGIBTKGQVWFTGX-BIIVOSGPSA-N 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108090000769 Isomerases Proteins 0.000 description 3
- 102000004195 Isomerases Human genes 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000013681 dietary sucrose Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 2
- WOPJVEMFXYHZEE-SRVKXCTJSA-N Asp-Phe-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WOPJVEMFXYHZEE-SRVKXCTJSA-N 0.000 description 2
- 241000723422 Catalpa Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 2
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- SVBXIUDNTRTKHE-CIUDSAMLSA-N Ala-Arg-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O SVBXIUDNTRTKHE-CIUDSAMLSA-N 0.000 description 1
- JAMAWBXXKFGFGX-KZVJFYERSA-N Ala-Arg-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JAMAWBXXKFGFGX-KZVJFYERSA-N 0.000 description 1
- MCKSLROAGSDNFC-ACZMJKKPSA-N Ala-Asp-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MCKSLROAGSDNFC-ACZMJKKPSA-N 0.000 description 1
- NJPMYXWVWQWCSR-ACZMJKKPSA-N Ala-Glu-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NJPMYXWVWQWCSR-ACZMJKKPSA-N 0.000 description 1
- QHASENCZLDHBGX-ONGXEEELSA-N Ala-Gly-Phe Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QHASENCZLDHBGX-ONGXEEELSA-N 0.000 description 1
- XHNLCGXYBXNRIS-BJDJZHNGSA-N Ala-Lys-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XHNLCGXYBXNRIS-BJDJZHNGSA-N 0.000 description 1
- CYBJZLQSUJEMAS-LFSVMHDDSA-N Ala-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C)N)O CYBJZLQSUJEMAS-LFSVMHDDSA-N 0.000 description 1
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 1
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 1
- CREYEAPXISDKSB-FQPOAREZSA-N Ala-Thr-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CREYEAPXISDKSB-FQPOAREZSA-N 0.000 description 1
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- IASNWHAGGYTEKX-IUCAKERBSA-N Arg-Arg-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(O)=O IASNWHAGGYTEKX-IUCAKERBSA-N 0.000 description 1
- ITVINTQUZMQWJR-QXEWZRGKSA-N Arg-Asn-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O ITVINTQUZMQWJR-QXEWZRGKSA-N 0.000 description 1
- FEZJJKXNPSEYEV-CIUDSAMLSA-N Arg-Gln-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O FEZJJKXNPSEYEV-CIUDSAMLSA-N 0.000 description 1
- YHQGEARSFILVHL-HJGDQZAQSA-N Arg-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N)O YHQGEARSFILVHL-HJGDQZAQSA-N 0.000 description 1
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 1
- DNUKXVMPARLPFN-XUXIUFHCSA-N Arg-Leu-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DNUKXVMPARLPFN-XUXIUFHCSA-N 0.000 description 1
- NOZYDJOPOGKUSR-AVGNSLFASA-N Arg-Leu-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O NOZYDJOPOGKUSR-AVGNSLFASA-N 0.000 description 1
- JEOCWTUOMKEEMF-RHYQMDGZSA-N Arg-Leu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JEOCWTUOMKEEMF-RHYQMDGZSA-N 0.000 description 1
- SSZGOKWBHLOCHK-DCAQKATOSA-N Arg-Lys-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N SSZGOKWBHLOCHK-DCAQKATOSA-N 0.000 description 1
- KSHJMDSNSKDJPU-QTKMDUPCSA-N Arg-Thr-His Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KSHJMDSNSKDJPU-QTKMDUPCSA-N 0.000 description 1
- QUBKBPZGMZWOKQ-SZMVWBNQSA-N Arg-Trp-Arg Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 QUBKBPZGMZWOKQ-SZMVWBNQSA-N 0.000 description 1
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- XUTOXNRSAGLAKO-UHFFFAOYSA-N Asn Val Asn Pro Chemical compound NC(=O)CC(N)C(=O)NC(C(C)C)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(O)=O XUTOXNRSAGLAKO-UHFFFAOYSA-N 0.000 description 1
- KSBHCUSPLWRVEK-ZLUOBGJFSA-N Asn-Asn-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KSBHCUSPLWRVEK-ZLUOBGJFSA-N 0.000 description 1
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 1
- IICZCLFBILYRCU-WHFBIAKZSA-N Asn-Gly-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IICZCLFBILYRCU-WHFBIAKZSA-N 0.000 description 1
- UDSVWSUXKYXSTR-QWRGUYRKSA-N Asn-Gly-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UDSVWSUXKYXSTR-QWRGUYRKSA-N 0.000 description 1
- NKLRWRRVYGQNIH-GHCJXIJMSA-N Asn-Ile-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O NKLRWRRVYGQNIH-GHCJXIJMSA-N 0.000 description 1
- GFGUPLIETCNQGF-DCAQKATOSA-N Asn-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O GFGUPLIETCNQGF-DCAQKATOSA-N 0.000 description 1
- OOXUBGLNDRGOKT-FXQIFTODSA-N Asn-Ser-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OOXUBGLNDRGOKT-FXQIFTODSA-N 0.000 description 1
- HPBNLFLSSQDFQW-WHFBIAKZSA-N Asn-Ser-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O HPBNLFLSSQDFQW-WHFBIAKZSA-N 0.000 description 1
- HPASIOLTWSNMFB-OLHMAJIHSA-N Asn-Thr-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O HPASIOLTWSNMFB-OLHMAJIHSA-N 0.000 description 1
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 1
- AXXCUABIFZPKPM-BQBZGAKWSA-N Asp-Arg-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O AXXCUABIFZPKPM-BQBZGAKWSA-N 0.000 description 1
- VBVKSAFJPVXMFJ-CIUDSAMLSA-N Asp-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N VBVKSAFJPVXMFJ-CIUDSAMLSA-N 0.000 description 1
- JGDBHIVECJGXJA-FXQIFTODSA-N Asp-Asp-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JGDBHIVECJGXJA-FXQIFTODSA-N 0.000 description 1
- SVFOIXMRMLROHO-SRVKXCTJSA-N Asp-Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SVFOIXMRMLROHO-SRVKXCTJSA-N 0.000 description 1
- YBMUFUWSMIKJQA-GUBZILKMSA-N Asp-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N YBMUFUWSMIKJQA-GUBZILKMSA-N 0.000 description 1
- GBSUGIXJAAKZOW-GMOBBJLQSA-N Asp-Ile-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GBSUGIXJAAKZOW-GMOBBJLQSA-N 0.000 description 1
- KQBVNNAPIURMPD-PEFMBERDSA-N Asp-Ile-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KQBVNNAPIURMPD-PEFMBERDSA-N 0.000 description 1
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 1
- CJUKAWUWBZCTDQ-SRVKXCTJSA-N Asp-Leu-Lys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O CJUKAWUWBZCTDQ-SRVKXCTJSA-N 0.000 description 1
- MYLZFUMPZCPJCJ-NHCYSSNCSA-N Asp-Lys-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MYLZFUMPZCPJCJ-NHCYSSNCSA-N 0.000 description 1
- LIJXJYGRSRWLCJ-IHRRRGAJSA-N Asp-Phe-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LIJXJYGRSRWLCJ-IHRRRGAJSA-N 0.000 description 1
- HRVQDZOWMLFAOD-BIIVOSGPSA-N Asp-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N)C(=O)O HRVQDZOWMLFAOD-BIIVOSGPSA-N 0.000 description 1
- ITGFVUYOLWBPQW-KKHAAJSZSA-N Asp-Thr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ITGFVUYOLWBPQW-KKHAAJSZSA-N 0.000 description 1
- HCOQNGIHSXICCB-IHRRRGAJSA-N Asp-Tyr-Arg Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)O HCOQNGIHSXICCB-IHRRRGAJSA-N 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 101100493710 Caenorhabditis elegans bath-40 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 240000008996 Empetrum rubrum Species 0.000 description 1
- 241000567798 Enterobacter sp. FMB-1 Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000556426 Erwinia rhapontici Species 0.000 description 1
- 241000588699 Erwinia sp. Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UFNSPPFJOHNXRE-AUTRQRHGSA-N Gln-Gln-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O UFNSPPFJOHNXRE-AUTRQRHGSA-N 0.000 description 1
- SMLDOQHTOAAFJQ-WDSKDSINSA-N Gln-Gly-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SMLDOQHTOAAFJQ-WDSKDSINSA-N 0.000 description 1
- HYPVLWGNBIYTNA-GUBZILKMSA-N Gln-Leu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HYPVLWGNBIYTNA-GUBZILKMSA-N 0.000 description 1
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 1
- WLRYGVYQFXRJDA-DCAQKATOSA-N Gln-Pro-Pro Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 WLRYGVYQFXRJDA-DCAQKATOSA-N 0.000 description 1
- YPFFHGRJCUBXPX-NHCYSSNCSA-N Gln-Pro-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(O)=O YPFFHGRJCUBXPX-NHCYSSNCSA-N 0.000 description 1
- UEILCTONAMOGBR-RWRJDSDZSA-N Gln-Thr-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UEILCTONAMOGBR-RWRJDSDZSA-N 0.000 description 1
- HPBKQFJXDUVNQV-FHWLQOOXSA-N Gln-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O HPBKQFJXDUVNQV-FHWLQOOXSA-N 0.000 description 1
- CSMHMEATMDCQNY-DZKIICNBSA-N Gln-Val-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CSMHMEATMDCQNY-DZKIICNBSA-N 0.000 description 1
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 1
- YLJHCWNDBKKOEB-IHRRRGAJSA-N Glu-Glu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O YLJHCWNDBKKOEB-IHRRRGAJSA-N 0.000 description 1
- WTMZXOPHTIVFCP-QEWYBTABSA-N Glu-Ile-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 1
- VMKCPNBBPGGQBJ-GUBZILKMSA-N Glu-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N VMKCPNBBPGGQBJ-GUBZILKMSA-N 0.000 description 1
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 1
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 1
- NPMSEUWUMOSEFM-CIUDSAMLSA-N Glu-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N NPMSEUWUMOSEFM-CIUDSAMLSA-N 0.000 description 1
- BHXSLRDWXIFKTP-SRVKXCTJSA-N Glu-Met-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N BHXSLRDWXIFKTP-SRVKXCTJSA-N 0.000 description 1
- HAGKYCXGTRUUFI-RYUDHWBXSA-N Glu-Tyr-Gly Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)O HAGKYCXGTRUUFI-RYUDHWBXSA-N 0.000 description 1
- MFYLRRCYBBJYPI-JYJNAYRXSA-N Glu-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O MFYLRRCYBBJYPI-JYJNAYRXSA-N 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- MHHUEAIBJZWDBH-YUMQZZPRSA-N Gly-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN MHHUEAIBJZWDBH-YUMQZZPRSA-N 0.000 description 1
- QPDUVFSVVAOUHE-XVKPBYJWSA-N Gly-Gln-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(O)=O QPDUVFSVVAOUHE-XVKPBYJWSA-N 0.000 description 1
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 1
- AAHSHTLISQUZJL-QSFUFRPTSA-N Gly-Ile-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AAHSHTLISQUZJL-QSFUFRPTSA-N 0.000 description 1
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 1
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 1
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- XINDHUAGVGCNSF-QSFUFRPTSA-N His-Ala-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XINDHUAGVGCNSF-QSFUFRPTSA-N 0.000 description 1
- BSVLMPMIXPQNKC-KBPBESRZSA-N His-Phe-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O BSVLMPMIXPQNKC-KBPBESRZSA-N 0.000 description 1
- UWSMZKRTOZEGDD-CUJWVEQBSA-N His-Thr-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O UWSMZKRTOZEGDD-CUJWVEQBSA-N 0.000 description 1
- DPTBVFUDCPINIP-JURCDPSOSA-N Ile-Ala-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DPTBVFUDCPINIP-JURCDPSOSA-N 0.000 description 1
- WECYRWOMWSCWNX-XUXIUFHCSA-N Ile-Arg-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O WECYRWOMWSCWNX-XUXIUFHCSA-N 0.000 description 1
- BGZIJZJBXRVBGJ-SXTJYALSSA-N Ile-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N BGZIJZJBXRVBGJ-SXTJYALSSA-N 0.000 description 1
- AQTWDZDISVGCAC-CFMVVWHZSA-N Ile-Asp-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N AQTWDZDISVGCAC-CFMVVWHZSA-N 0.000 description 1
- AREBLHSMLMRICD-PYJNHQTQSA-N Ile-His-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N AREBLHSMLMRICD-PYJNHQTQSA-N 0.000 description 1
- ZUPJCJINYQISSN-XUXIUFHCSA-N Ile-Met-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)N ZUPJCJINYQISSN-XUXIUFHCSA-N 0.000 description 1
- XVUAQNRNFMVWBR-BLMTYFJBSA-N Ile-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N XVUAQNRNFMVWBR-BLMTYFJBSA-N 0.000 description 1
- 108010010525 Isomaltulose synthase Proteins 0.000 description 1
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- XBBKIIGCUMBKCO-JXUBOQSCSA-N Leu-Ala-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XBBKIIGCUMBKCO-JXUBOQSCSA-N 0.000 description 1
- USTCFDAQCLDPBD-XIRDDKMYSA-N Leu-Asn-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N USTCFDAQCLDPBD-XIRDDKMYSA-N 0.000 description 1
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 1
- HQUXQAMSWFIRET-AVGNSLFASA-N Leu-Glu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HQUXQAMSWFIRET-AVGNSLFASA-N 0.000 description 1
- HMDDEJADNKQTBR-BZSNNMDCSA-N Leu-His-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMDDEJADNKQTBR-BZSNNMDCSA-N 0.000 description 1
- USLNHQZCDQJBOV-ZPFDUUQYSA-N Leu-Ile-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O USLNHQZCDQJBOV-ZPFDUUQYSA-N 0.000 description 1
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 1
- AUNMOHYWTAPQLA-XUXIUFHCSA-N Leu-Met-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AUNMOHYWTAPQLA-XUXIUFHCSA-N 0.000 description 1
- JIHDFWWRYHSAQB-GUBZILKMSA-N Leu-Ser-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JIHDFWWRYHSAQB-GUBZILKMSA-N 0.000 description 1
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 1
- YRWCPXOFBKTCFY-NUTKFTJISA-N Lys-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCCN)N YRWCPXOFBKTCFY-NUTKFTJISA-N 0.000 description 1
- ALSRJRIWBNENFY-DCAQKATOSA-N Lys-Arg-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O ALSRJRIWBNENFY-DCAQKATOSA-N 0.000 description 1
- DFXQCCBKGUNYGG-GUBZILKMSA-N Lys-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN DFXQCCBKGUNYGG-GUBZILKMSA-N 0.000 description 1
- LLSUNJYOSCOOEB-GUBZILKMSA-N Lys-Glu-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O LLSUNJYOSCOOEB-GUBZILKMSA-N 0.000 description 1
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 1
- GZGWILAQHOVXTD-DCAQKATOSA-N Lys-Met-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O GZGWILAQHOVXTD-DCAQKATOSA-N 0.000 description 1
- RQILLQOQXLZTCK-KBPBESRZSA-N Lys-Tyr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O RQILLQOQXLZTCK-KBPBESRZSA-N 0.000 description 1
- OHXUUQDOBQKSNB-AVGNSLFASA-N Lys-Val-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OHXUUQDOBQKSNB-AVGNSLFASA-N 0.000 description 1
- GAELMDJMQDUDLJ-BQBZGAKWSA-N Met-Ala-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O GAELMDJMQDUDLJ-BQBZGAKWSA-N 0.000 description 1
- RIIFMEBFDDXGCV-VEVYYDQMSA-N Met-Thr-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O RIIFMEBFDDXGCV-VEVYYDQMSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 241000520272 Pantoea Species 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- BKWJQWJPZMUWEG-LFSVMHDDSA-N Phe-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BKWJQWJPZMUWEG-LFSVMHDDSA-N 0.000 description 1
- XMPUYNHKEPFERE-IHRRRGAJSA-N Phe-Asp-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 XMPUYNHKEPFERE-IHRRRGAJSA-N 0.000 description 1
- RIYZXJVARWJLKS-KKUMJFAQSA-N Phe-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RIYZXJVARWJLKS-KKUMJFAQSA-N 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- JQLQUPIYYJXZLJ-ZEWNOJEFSA-N Phe-Ile-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 JQLQUPIYYJXZLJ-ZEWNOJEFSA-N 0.000 description 1
- OQTDZEJJWWAGJT-KKUMJFAQSA-N Phe-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O OQTDZEJJWWAGJT-KKUMJFAQSA-N 0.000 description 1
- AXIOGMQCDYVTNY-ACRUOGEOSA-N Phe-Phe-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 AXIOGMQCDYVTNY-ACRUOGEOSA-N 0.000 description 1
- ILGCZYGFYQLSDZ-KKUMJFAQSA-N Phe-Ser-His Chemical compound N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O ILGCZYGFYQLSDZ-KKUMJFAQSA-N 0.000 description 1
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 1
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 1
- ONPFOYPPPOHMNH-UVBJJODRSA-N Pro-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@@H]3CCCN3 ONPFOYPPPOHMNH-UVBJJODRSA-N 0.000 description 1
- CYQQWUPHIZVCNY-GUBZILKMSA-N Pro-Arg-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CYQQWUPHIZVCNY-GUBZILKMSA-N 0.000 description 1
- WPQKSRHDTMRSJM-CIUDSAMLSA-N Pro-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 WPQKSRHDTMRSJM-CIUDSAMLSA-N 0.000 description 1
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 1
- FISHYTLIMUYTQY-GUBZILKMSA-N Pro-Gln-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 FISHYTLIMUYTQY-GUBZILKMSA-N 0.000 description 1
- YSUZKYSRAFNLRB-ULQDDVLXSA-N Pro-Gln-Trp Chemical compound N([C@@H](CCC(=O)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C(=O)[C@@H]1CCCN1 YSUZKYSRAFNLRB-ULQDDVLXSA-N 0.000 description 1
- XQSREVQDGCPFRJ-STQMWFEESA-N Pro-Gly-Phe Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XQSREVQDGCPFRJ-STQMWFEESA-N 0.000 description 1
- SWRNSCMUXRLHCR-ULQDDVLXSA-N Pro-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 SWRNSCMUXRLHCR-ULQDDVLXSA-N 0.000 description 1
- QKDIHFHGHBYTKB-IHRRRGAJSA-N Pro-Ser-Phe Chemical compound N([C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1 QKDIHFHGHBYTKB-IHRRRGAJSA-N 0.000 description 1
- GNFHQWNCSSPOBT-ULQDDVLXSA-N Pro-Trp-Gln Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CCC(=O)N)C(=O)O GNFHQWNCSSPOBT-ULQDDVLXSA-N 0.000 description 1
- MWMKFWJYRRGXOR-ZLUOBGJFSA-N Ser-Ala-Asn Chemical compound N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(N)=O)C)CO MWMKFWJYRRGXOR-ZLUOBGJFSA-N 0.000 description 1
- WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 1
- IDCKUIWEIZYVSO-WFBYXXMGSA-N Ser-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C)C(O)=O)=CNC2=C1 IDCKUIWEIZYVSO-WFBYXXMGSA-N 0.000 description 1
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 1
- WSTIOCFMWXNOCX-YUMQZZPRSA-N Ser-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N WSTIOCFMWXNOCX-YUMQZZPRSA-N 0.000 description 1
- XERQKTRGJIKTRB-CIUDSAMLSA-N Ser-His-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CN=CN1 XERQKTRGJIKTRB-CIUDSAMLSA-N 0.000 description 1
- SFTZTYBXIXLRGQ-JBDRJPRFSA-N Ser-Ile-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SFTZTYBXIXLRGQ-JBDRJPRFSA-N 0.000 description 1
- MUJQWSAWLLRJCE-KATARQTJSA-N Ser-Leu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MUJQWSAWLLRJCE-KATARQTJSA-N 0.000 description 1
- PJIQEIFXZPCWOJ-FXQIFTODSA-N Ser-Pro-Asp Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O PJIQEIFXZPCWOJ-FXQIFTODSA-N 0.000 description 1
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 1
- VAIWUNAAPZZGRI-IHPCNDPISA-N Ser-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CO)N VAIWUNAAPZZGRI-IHPCNDPISA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241001622809 Serratia plymuthica Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108020000005 Sucrose phosphorylase Proteins 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 1
- QILPDQCTQZDHFM-HJGDQZAQSA-N Thr-Gln-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QILPDQCTQZDHFM-HJGDQZAQSA-N 0.000 description 1
- MCDVZTRGHNXTGK-HJGDQZAQSA-N Thr-Met-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O MCDVZTRGHNXTGK-HJGDQZAQSA-N 0.000 description 1
- OLFOOYQTTQSSRK-UNQGMJICSA-N Thr-Pro-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OLFOOYQTTQSSRK-UNQGMJICSA-N 0.000 description 1
- IWAVRIPRTCJAQO-HSHDSVGOSA-N Thr-Pro-Trp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O IWAVRIPRTCJAQO-HSHDSVGOSA-N 0.000 description 1
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 1
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 1
- BPGDJSUFQKWUBK-KJEVXHAQSA-N Thr-Val-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 BPGDJSUFQKWUBK-KJEVXHAQSA-N 0.000 description 1
- TZNNEYFZZAHLBL-BPUTZDHNSA-N Trp-Arg-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O TZNNEYFZZAHLBL-BPUTZDHNSA-N 0.000 description 1
- RNFZZCMCRDFNAE-WFBYXXMGSA-N Trp-Asn-Ala Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O RNFZZCMCRDFNAE-WFBYXXMGSA-N 0.000 description 1
- FKAPNDWDLDWZNF-QEJZJMRPSA-N Trp-Asp-Glu Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N FKAPNDWDLDWZNF-QEJZJMRPSA-N 0.000 description 1
- OBWQLWYNNZPWGX-QEJZJMRPSA-N Trp-Gln-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O OBWQLWYNNZPWGX-QEJZJMRPSA-N 0.000 description 1
- MICSYKFECRFCTJ-IHRRRGAJSA-N Tyr-Arg-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O MICSYKFECRFCTJ-IHRRRGAJSA-N 0.000 description 1
- TWAVEIJGFCBWCG-JYJNAYRXSA-N Tyr-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N TWAVEIJGFCBWCG-JYJNAYRXSA-N 0.000 description 1
- WSFXJLFSJSXGMQ-MGHWNKPDSA-N Tyr-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N WSFXJLFSJSXGMQ-MGHWNKPDSA-N 0.000 description 1
- PRONOHBTMLNXCZ-BZSNNMDCSA-N Tyr-Leu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PRONOHBTMLNXCZ-BZSNNMDCSA-N 0.000 description 1
- LVFZXRQQQDTBQH-IRIUXVKKSA-N Tyr-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O LVFZXRQQQDTBQH-IRIUXVKKSA-N 0.000 description 1
- TYGHOWWWMTWVKM-HJOGWXRNSA-N Tyr-Tyr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 TYGHOWWWMTWVKM-HJOGWXRNSA-N 0.000 description 1
- RVGVIWNHABGIFH-IHRRRGAJSA-N Tyr-Val-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O RVGVIWNHABGIFH-IHRRRGAJSA-N 0.000 description 1
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 1
- ISERLACIZUGCDX-ZKWXMUAHSA-N Val-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N ISERLACIZUGCDX-ZKWXMUAHSA-N 0.000 description 1
- DDNIHOWRDOXXPF-NGZCFLSTSA-N Val-Asp-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DDNIHOWRDOXXPF-NGZCFLSTSA-N 0.000 description 1
- PWRITNSESKQTPW-NRPADANISA-N Val-Gln-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N PWRITNSESKQTPW-NRPADANISA-N 0.000 description 1
- SZTTYWIUCGSURQ-AUTRQRHGSA-N Val-Glu-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SZTTYWIUCGSURQ-AUTRQRHGSA-N 0.000 description 1
- BZMIYHIJVVJPCK-QSFUFRPTSA-N Val-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N BZMIYHIJVVJPCK-QSFUFRPTSA-N 0.000 description 1
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 1
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 1
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 1
- AIWLHFZYOUUJGB-UFYCRDLUSA-N Val-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 AIWLHFZYOUUJGB-UFYCRDLUSA-N 0.000 description 1
- 241000083686 [Pseudomonas] mesoacidophila Species 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 1
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 1
- 108010094001 arginyl-tryptophyl-arginine Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- SXYIRMFQILZOAM-HVNFFKDJSA-N dihydroartemisinin methyl ether Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OC)O[C@H]4[C@]32OO[C@@]1(C)O4 SXYIRMFQILZOAM-HVNFFKDJSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 150000002410 histidine derivatives Chemical class 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 1
- 108010078274 isoleucylvaline Proteins 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- FBJQEBRMDXPWNX-FYHZSNTMSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-FYHZSNTMSA-N 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 108010044348 lysyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000036438 mutation frequency Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108010084525 phenylalanyl-phenylalanyl-glycine Proteins 0.000 description 1
- 108010024654 phenylalanyl-prolyl-alanine Proteins 0.000 description 1
- 108010083476 phenylalanyltryptophan Proteins 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003267 reducing disaccharides Chemical class 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 108010045269 tryptophyltryptophan Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 108010071635 tyrosyl-prolyl-arginine Proteins 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/99—Intramolecular transferases (5.4) transferring other groups (5.4.99)
- C12Y504/99022—23S rRNA pseudouridine2605 synthase (5.4.99.22)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention belongs to the technical field of biology, and particularly relates to a sucrose isomerase mutant from Erwiniasp.Ejp617, a coding gene thereof, a recombinant vector containing the mutant gene and application of the sucrose isomerase mutant in preparing isomaltulose by biocatalysis of sucrose. The amino acid sequence of the sucrose isomerase mutant is shown as SEQ ID NO. 1. The invention constructs a sucrose isomerase double mutant Q209S/R456H with improved enzyme activity and catalysis efficiency, and the enzyme activity of the sucrose isomerase mutant Q209S/R456H reaches 684U/mg in water bath with pH of 6.0 and 30 ℃, and the catalysis efficiency is more than 16 times of that of wild sucrose isomerase; enzyme kinetic analysis shows that Q209S/R456H K m The values were respectively reduced by 48.7% and k compared with the native enzyme cat The value is 8.3 times of that of the natural enzyme; catalytic efficiency k cat /K m Is more than 16 times of the WT. When the sucrose is catalyzed to produce isomaltulose, the maximum conversion rate of the isomaltulose of the mutant is improved by 19.3 percent compared with that of the natural enzyme.
Description
Field of the art
The invention belongs to the technical field of biology, and particularly relates to a sucrose isomerase mutant from Erwiniasp.Ejp617, a coding gene thereof, a recombinant vector containing the mutant gene and application of the sucrose isomerase mutant in preparing isomaltulose by biocatalysis of sucrose.
(II) background art
Isomaltulose (isomaltose), also known as Palatinose (Palatinose), is a reducing disaccharide, an isomer of sucrose, composed of D-glucose and D-fructose joined by an alpha-1, 6 glycosidic bond, unlike the alpha-1, 2 glycosidic bond in sucrose. In 1957, it was first discovered by Weienhagen et al in beet production. Isomaltulose has a sweetness profile and mouthfeel similar to sucrose, but its sweetness is low, only 52% of sucrose, and its outstanding advantages compared to sucrose are mainly represented by: (1) low cariogenic properties; (2) Has good therapeutic effect on diabetic and pre-diabetic patients; (3) Selectively stimulating the growth of bifidobacteria in the human intestinal tract; (4) Very low hygroscopicity, strong stability and longer shelf life; (5) Is suitable for the people such as middle and primary school students, white collar people and the like who need to continuously and long-time mental work. Isomaltulose has been widely used as a promising functional sweetener in japan, the united states, western europe, etc., and has a range of applications including hard candy, soft candy, chewing gum, chocolate, baked goods, fruit cans, jams, sports drinks, toothpastes, etc. Isomaltulose is also a starting material for Isomalt (isomart). Isomaltulose alcohol is a functional sugar alcohol which is internationally emerging in recent years and is widely applied to the production of products such as sugarless foods, sugarless health-care products, sugarless medicines and the like.
Isomaltulose is produced by sucrose isomerase EC 5.4.99.22 (Sucrose isomerase), or isomaltulose synthase (Isomaltulose syntheses), sucrose glucosyltransferase (Sucrose glucosylmutase), α -glucosyltransferase (α -glucosyltransferase), which rearranges the α -1,2 linkage of glucose and fructose in sucrose, to produce trehalose when rearranged to α -1,4 linkages, and to isomaltulose when rearranged to α -1,6 linkages. Currently, sucrose isomerase used for isomaltulose production is derived from various microorganisms such as E.coli NX-5, E.coli D12 (Erwinia sp.D12), serratia ATCC15928 (Serratia plymuthica ATCC 15928), klebsiella, pseudomonas acidophilus MX-45 (Pseudomonas mesoacidophila MX-45) and E.coli NCPPB1578 (E.rhapontici NCPPB 1578), natural enzymes from E.coli DSM4484 (GenBank accession number AAK 28735.1), E.coli NX-5 (ADJ 56407.2), E.coli FMB-1 (Enterobacter sp.FMB-1) (ACF 42098.1), pseudomonas acidophilus MX-45 (ACO 05018.1), E.rubrum CBS574.77 (CAF 32985.1), klebsiella pneumoniae NK33-98-8 (Klebsiella pneumonia NK-98-8) (AAM 96902.1), UQ68 (49) and Klebsiella X33-98-8) (AAM 96902.1), klebsiella de (AAK 82938.1) and recombinant enzymes from E.coli LXYZ.sp.5 (ADJ 56407.2). Although sucrose isomerase produced by the above-mentioned bacteria can convert sucrose into isomaltulose, the yield is very unstable and the conversion rate is not high, which is 8% -85%. In addition, besides the main product, partial trehalose and a small amount of byproducts such as isomaltose, isomaltotriose, glucose, fructose and the like exist in the enzyme conversion solution, so that the product specificity is not high. In order to increase the enzyme activity of sucrose isomerase to increase the yield of isomaltulose, the production of isomaltulose high-producing strain by various mutation methods is also a big hot spot of current research. According to Zhang Hongda, klebsiella LX3 screened in a laboratory is taken as an initial strain, the strain is subjected to mutagenesis by using a normal pressure room temperature plasma injection technology, and the saccharose isomerase activity, the isomaltulose content and the detection of the bacterial flocculation effect in fermentation liquor are measured to obtain a strain (LX 3-1) with high isomaltulose yield and lower viscosity, compared with a wild strain, the enzyme activity of the saccharose isomerase of a mutant strain is improved by 20.42% (P < 0.05), the yield of the isomaltulose is improved by 41.87%, and after 6 subcultures of the mutant strain, the enzyme activity of the saccharose isomerase and the yield of the isomaltulose in the fermentation liquor are still stable. Liu et al mutated Y296 and Q299 of sucrose isomerase derived from Pantoea dispersible UQ68J near the substrate binding site, to achieve improved isomaltulose production.
At present, although there are many researches on sucrose isomerase at home and abroad, most of the researches remain at laboratory level, and further researches on the industrial application of sucrose isomerase are needed.
(III) summary of the invention
The invention aims to provide a sucrose isomerase mutant, a coding gene thereof, a recombinant vector containing the mutant gene and application of the sucrose isomerase mutant in preparing isomaltulose by biologically catalyzing sucrose.
The technical scheme adopted by the invention is as follows:
a sucrose isomerase mutant has an amino acid sequence shown in SEQ ID NO. 1. The sucrose isomerase mutant is obtained by mutating the 209 th amino acid from Erwiniasp. Ejp617 from glutamine to serine and mutating the 456 th arginine to histidine. The invention uses error-prone PCR technology to carry out site-directed mutagenesis on sucrose isomerase for molecular transformation, thereby further improving the enzyme activity of sucrose isomerase and the yield of isomaltulose.
The invention also relates to a gene encoding the sucrose isomerase mutant.
Specifically, the nucleotide sequence of the coding gene is shown as SEQ ID No. 2.
The invention also relates to a recombinant vector containing the coding gene. These genes, expression cassettes, plasmids, transformants can be obtained by genetic engineering construction methods well known to those skilled in the art.
The invention also relates to application of the sucrose isomerase mutant in preparing isomaltulose by biocatalysis of sucrose.
When used as biocatalysts for production, the sucrose isomerase mutants of the present invention may take the form of enzymes or bacteria. The enzyme forms include free enzymes, immobilized enzymes, including purified enzymes, crude enzymes, fermentation broths, vector immobilized enzymes, cell debris, etc.: the forms of the bacterial cells include viable bacterial cells and dead bacterial cells.
Specifically, the application is as follows: the sucrose isomerase mutant is used as a catalyst, sucrose is used as a substrate, the reaction is carried out for 3 to 12 hours at the pH of 6.0 to 7.0 and the temperature of 28 to 32 ℃, and the isomaltulose is obtained in the reaction liquid.
Preferably, the concentration of sucrose in the reaction system is 500-600 g/L.
Compared with the prior art, the invention has the beneficial effects that: the invention constructs a sucrose isomerase double mutant Q209S/R456H with improved enzyme activity and catalysis efficiency, and the enzyme activity of the sucrose isomerase mutant Q209S/R456H reaches 684U/mg in water bath with pH of 6.0 and 40 ℃, and the catalysis efficiency is more than 16 times of that of wild sucrose isomerase; enzyme kinetic analysis shows that Q209S/R456H K m The values respectively decrease compared with the natural enzymes48.7%, k cat The value is 8.3 times of that of the natural enzyme; catalytic efficiency k cat /K m Is more than 16 times of the WT. When the sucrose is catalyzed to produce isomaltulose, the maximum conversion rate of the isomaltulose of the mutant is improved by 19.3 percent compared with that of the natural enzyme.
(IV) description of the drawings
Fig. 1: the method is to obtain good mutation point color reaction by using a high-throughput screening method;
fig. 2: is natural sucrose isomerase and five mutant pure enzyme SDS-PAGE gel electrophoresis; wherein M represents a protein molecular weight standard, WT is wild-type sucrose isomerase, and lane 1 is mutant Q209N; lane 2 is mutant R456K; lane 3 is mutant Q209S, lane 4 is mutant R456H, and lane 5 is mutant Q209S-R456H.
Fig. 3: optimum temperature and pH values for ErSIase_WT and ErSIase_Q209S-R456H. (A) optimum temperature of the ErSIase_WT, (B) optimum pH of the ErSIase_WT, (C) optimum temperature of the ErSIase_Q209S-R456H, and (D) optimum pH of the ErSIase_Q209S-R456H.
Fig. 4: the conversion of isomaltulose was prepared for the wild-type sucrose isomerase and its mutants at 40 ℃.
Fig. 5: construction of recombinant E.coli BL21 (DE 3)/pET 28b (+) -ErSIase containing recombinant plasmid of ErSIase gene.
(fifth) detailed description of the invention
The present invention will be described in further detail with reference to the following specific examples, but the present invention is not limited to the following examples:
the invention relates to the addition amount, content and concentration of various substances, wherein the percentage content refers to the mass percentage content unless specified otherwise.
Reagents for upstream genetic engineering operations: the one-step cloning kits used in the examples of the present invention were all purchased from Vazyme, nanjinouzan biotechnology Co., ltd; plasmid extraction kit DNA recovery purification kits were purchased from Axygen hangzhou limited; plasmids and the like are purchased from Shanghai; DNA marker, fast Pfu DNA polymerase, low molecular weight standard protein, agarose electrophoresis reagent, primer synthesis and gene sequencing and gene synthesis work are completed by catalpa and Xeong biotechnology limited company of Hangzhou qing. The above methods of reagent use are referred to in the commercial specifications. Common reagents such as sucrose and isomaltulose are purchased from national pharmaceutical group chemical company, ltd.
Example 1: cloning and expression of the sucrose isomerase gene in E.coli BL21 (DE 3).
Constructing an expression vector: the sucrose isomerase gene synthesis described below was performed by catalpa, biotechnology limited, of qinghao. The sucrose isomerase gene (GenBank: G37835) derived from Erwinia (Erwiniasp. Ejp 617) was seamlessly cloned between the Nco I and Xho I of the pET28b (+) vector by PCR to obtain the expression vector pET28b (+) -SI with sucrose isomerase. The PCR procedure was as follows: pre-denaturation at 95 ℃ for 3 min; denaturation at 95℃for 15s, annealing at 53-58℃for 15s, extension at 72℃for 1.5 min for 25 cycles; then extended at 72℃for 10 minutes.
The preparation method of the competent cells comprises the following steps: e.coli BL21 (DE 3) strain preserved in glycerol tubes is obtained from a refrigerator at the temperature of minus 80 ℃, streaks are formed on an antibiotic-free LB plate, and the strain is cultured for 10 hours at the temperature of 37 ℃ to obtain single colony; picking single colony of LB plate, inoculating into test tube containing 5mL LB culture medium, culturing at 37deg.C and 180rpm for 9h; 200 mu L of bacterial liquid is taken from a test tube and inoculated into 50mL of LB culture medium, OD is cultivated at 37 ℃ and 180rpm 600 To 0.4-0.6; precooling the bacterial liquid on ice, taking the bacterial liquid into a sterilized centrifuge tube, placing the bacterial liquid on the ice for 10min, and centrifuging the bacterial liquid at 4 ℃ for 10min at 5000 rpm; pouring out supernatant, taking care to prevent contamination, pre-cooling with 0.1mol/L CaCl 2 The precipitated cells were resuspended in aqueous solution and placed on ice for 30min; centrifuging at 4deg.C and 5000rpm for 10min, discarding supernatant, and pre-cooling with 0.1mol/L CaCl containing 15% glycerol 2 The precipitated cells were resuspended in aqueous solution, 100. Mu.L of the resuspended cells were dispensed into sterilized 1.5mL centrifuge tubes and stored in a-80℃freezer and removed as needed.
Constructing an engineering bacteria library: e.coli BL21 (DE 3) (Invitrogen) competent cells stored at-80℃were ice-bathed at 0℃for 10min, then 5. Mu.L of pET28b (+) -SI with sucrose isomerase gene expression vector was added in a super clean bench, respectively, ice-bathed at 0℃for 30min, hot-shocked at 42℃in water bath, ice-bathed at 0℃for 4min, 600. Mu.L of LB medium was added, and shaking culture was performed at 37℃and 200rpm for 1h; coating on LB plate containing 50 mug/ml kanamycin resistance, culturing at 37 ℃ for 8-12h to obtain recombinant E.coli BL21 (DE 3)/pET 28b (+) -SI engineering bacteria containing expression recombinant plasmid.
Example 2: induction expression and purification of sucrose isomerase recombinant bacteria
Wet cell containing sucrose isomerase: the recombinant E.coli BL21 (DE 3)/pET 28b (+) -SI obtained in example 2 was inoculated into LB liquid medium containing 50. Mu.g/mL kanamycin resistance, cultured at 37℃and 200rpm for 12 hours, inoculated into fresh LB liquid medium containing 50. Mu.g/mL kanamycin resistance in an inoculum size of 1% (v/v), and cultured at 150rpm to cell OD at 37℃ 600 Adding IPTG with the final concentration of 0.1mM to 0.6-0.8, performing induction culture at 25 ℃ for 10 hours, centrifuging at 4 ℃ and 8000rpm for 20 minutes, discarding supernatant, collecting precipitate, and washing twice with Tris HCl buffer solution with the pH of 7.0 and 50mM to obtain a recombinant strain E.coli BL21 (DE 3)/pET 28b (+) -SI wet bacterial strain containing sucrose isomerase; the wet cells were resuspended in 50mM Tris HCl buffer pH 7.0 and sonicated on an ice-water mixture for 20min under sonication conditions: the power was 400W, the mixture was broken for 1s and suspended for 5s to obtain a crude enzyme solution.
Purification of sucrose isomerase: since 6 histidine tags are expressed together with the sucrose isomerase gene, the peptide fragment and divalent Ni that can be expressed by this histidine tag 2+ Is purified by affinity chromatography using Ni affinity columns (40X 12.6mm, bio-Rad, USA). The purification process is mainly used and performed. The specific operation is as follows: (1) buffer A (50 mM NaH) was equilibrated with 5 column volumes of Ni column 2 PO 4 ·2H 2 The Ni column was equilibrated with O+300mM NaCl+50mM imidazole to baseline stability; (2) sample loading, wherein the flow rate is 1mL/min, the loading amount is 25-40mg/mL of protein, and the target protein is adsorbed on a Ni column; (3) flushing the hybrid protein with buffer A with 6 times of column volume, and stabilizing the flow rate to a baseline at 1 mL/min; (4) with eluent B (50 mM NaH 2 PO 4 ·2H 2 O+300mM NaCl+500mM imidazole) at a flow rate of 1mL/min, and collecting the target protein. The target protein was dialyzed overnight in a phosphate buffer solution (pH 7.5, 20 mM), and purified enzyme was obtained, and the SDS-PAGE pattern was shown in FIG. 2.
Example 3 construction and screening of sucrose isomerase Gene library.
(one) introduction of beneficial mutations by error-prone PCR
Plasmid DNA was isolated from E.coli BL21 (DE 3)/pET 28b (+) -SI recombinant E.coli using the MiniBEST plasmid purification kit (TaKaRa, dalian, china). In the presence of 60ng of plasmid (pET 28 b-SI) as template, 60pmol of each mutagenesis primer (Table S1), 0.4mM MnCl 2 Amplification of DNA fragments Taq PCR Starmix and Loding Dye (TaKaRa, daidan, china) was performed in 50. Mu.L of the reaction mixture of 2X. The amplification process of the gene encoding the SIase is: 94℃for 2min, followed by 30 cycles of 94℃ 30s,60℃30s and 72℃2min, respectively, and finally 10min at 72 ℃. This protocol resulted in an average mutation frequency of every 1000bpAnd (3) substitution of a single base. The PCR product was digested with QuickCut Dpn I at 37℃for 3 hours to remove the template. The library gene fragments were then purified using MiniBEST DNA fragment purification kit (TaKaRa, dalian, china). The purified gene fragment was then ligated into pET28b between the Nco I and Xho I sites to form recombinant plasmid pET28b-SI. pET28b-SI was then transformed into E.coli and all transformed cells were grown overnight. The best variants were screened and sequenced.
Table S1: error-prone PCR primer sequences
(II) establishment of high throughput screening method and detailed procedure
1. Preparing seed liquid by 96 deep hole plate culture: 500. Mu.L of LB liquid medium containing 0.1% (v/v) 100g/LKana was added to each well of the 96-deep well plate, then single colonies were picked up with sterile toothpicks into the corresponding wells, and the remaining 4 wells were selected from each 96-deep well plate, and WT single colonies were picked up and added as positive controls. Then, the mixture was sealed with a cap, and cultured at 37℃and 180rpm with shaking for 5 hours.
2. Seed liquid transfer and induction: taking 50 mu L of the seed liquid of the transformant cultured in the previous step into another 96 deep well plate, adding 900 mu L of LB liquid medium containing 0.1% (v/v) 100g/L Kan, sealing by a cover, culturing for 2h at 37 ℃ with shaking at 180rpm, adding 50 mu L of LB liquid medium containing 0.8% (v/v) 120g/L IPTG and 0.1% (v/v) 100g/L Kana into each well, sealing by the cover, and culturing for more than 10h with shaking at 25 ℃ and 180 rpm. The remaining seed solution of the transformant was kept in a refrigerator at 4℃for further use.
3. Enzymatic activity detection by DNS method: mu.L of the induced solution was taken in a 96-well plate, and 50. Mu.L of 50g/L sucrose (prepared with 50mM citric acid-disodium hydrogen phosphate buffer (pH 6.0)) was added thereto, and reacted at a constant temperature of 40℃for 15 minutes. Then 50 mu L of DNS reagent is added, the color is developed by heating for about 25s with medium fire in a microwave oven, the experimental result is observed, and the absorbance of the developing solution at 540nm is detected by an enzyme-labeled instrument.
4. Preserving and sequencing high-enzyme activity mutant bacterial liquid: according to the determination result of the DNS method, labeling a sample with higher absorbance than that of the positive control, taking 200 mu L of the corresponding seed liquid in a glycerol tube, adding 200 mu L of 50% glycerol, uniformly mixing, and then storing in a refrigerator at the temperature of minus 20 ℃. Then 10 mu L of seed solution is taken and cultured in 10mL of LB liquid medium containing 0.1% (v/v) 100g/L Kan at 37 ℃ under shaking at 180rpm for more than 7 hours, more than 200 mu L of bacterial solution is taken and tested, and proper mutants are reserved according to the sequencing result.
And (III) carrying out re-screening by using a High Performance Liquid Chromatography (HPLC) method
High Performance Liquid Chromatography (HPLC) to determine enzyme activity: 200. Mu.L of the crude enzyme solution (100 g/L of the supernatant after ultrasonic disruption of wet cells) was added to 800. Mu.L of 50mM citric acid-disodium hydrogen phosphate buffer (pH 6.0) containing sucrose (sucrose final concentration: 50 g/L). After 30min of reaction at 40 ℃, the mixture is treated by boiling water bath for 10min for inactivation. The centrifuged supernatant was diluted 5-fold with a mobile phase, filtered through a filter membrane, and the isomaltulose content in the diluted solution was measured by high performance liquid chromatography. Liquid chromatography usedThe instrument is waters2414; the mobile phase is acetonitrile and water mixed solution with the volume ratio of 4:1, and the flow rate is 1.5mL/min; the chromatographic column is special for Agilent ZORBAX sugar analysis (specification 4.6X1250 mm, carbon loading 3.5%, pore diameter 70 angstrom, particle diameter 5 μm, specific surface area 300 m) 2 /g, pH range 2.0-8.0); the detector is a differential refraction detector; the external temperature and the column temperature are 35 ℃ and 30 ℃ respectively; the sample loading was 10. Mu.L. Calibration of a high performance liquid chromatography standard curve: sucrose solutions and isomaltulose solutions of different concentrations (1 mM, 10mM, 20mM, 40mM, 80mM and 120 mM) were prepared, the peak areas thereof were measured by HPLC methods, respectively, and the sucrose solutions (or isomaltulose solutions) were plotted on the abscissa and the peak areas on the ordinate, respectively, to draw the relevant standard curves.
Definition of enzyme Activity: the amount of enzyme required to catalyze sucrose isomerization to 1. Mu. Mol isomaltulose in 1min at pH6.0 and 40℃is 1 enzyme activity unit (U).
The calculation formula of the specific activity of the pure enzyme is as follows:
after 4500 mutants were screened, two optimal mutants Q209N, R456K, E.coli BL21 (DE 3)/pET 28b (+) -SI-Q209N and E.coli BL21 (DE 3)/pET 28b (+) -SI R456K were obtained with the enzyme activities reaching 59U/mg,165U/mg, respectively, whereas the wild type E.coli BL21 (DE 3)/pET 28b (+) -SI enzyme activity was 39U/mg protein, the specific activities of mutants Q209N and R456K were increased by 1.5 and 4.2 times, respectively.
Example 4: site-directed saturation mutation of sucrose isomerase
In order to further screen potential activity-improving strains, the two beneficial mutation sites Q209 and R456 of the sucrose isomerase obtained in example 3 are subjected to site-directed saturation mutation, and further screening is carried out, wherein PCR primer design is shown in Table 1, and a PCR system (50 mu L) is as follows: 2.times.Phanta Max buffer 25. Mu.L, dNTPs 1. Mu.L, mutation upper and lower primers 1. Mu.L each, template (starting strain) 1. Mu.L, pfu DNA polymerase 0.5. Mu.L, and ddH 2 O to 50. Mu.L. The PCR conditions were: pre-denaturation at 95 ℃ for 3min: denaturation at 95℃for 15s, annealing at 60℃for 15s, extension at 72 ℃Stretching for 7min for 20s, and circulating for 30 times; final extension at 72℃for 10min. The PCR product is verified by DNA agarose gel electrophoresis, and after passing through DpnI digestion template, the PCR product is transformed into E.coli BL21 (DE 3) competent cells, the transformed product is coated on LB plate containing 50 mug/mL ampicillin resistance, the inversion culture is carried out at 37 ℃ for overnight, the obtained mutant is screened for dominant mutant, and the obtained dominant strain is sent to Hangzhou department of the biological technology of the field of China for sequencing confirmation and preservation.
Table 1: sucrose isomerase site-directed saturation mutation primer design
Liquid phase detection the enzyme activity was calculated as in example 3 above.
After site-directed saturation mutation of the two beneficial mutation sites Q209 and R456 of sucrose isomerase, it was found that the enzyme activities of mutants Q209S and R456H were increased 7.3-fold and 11.5-fold, respectively, with the exception of Q209N and R456K as beneficial mutation sites, with a greater magnitude than that of mutants Q209N and R456K. Then, the Q209N and R456K mutants are combined to obtain a double mutant E.coli BL21 (DE 3)/pET 28b (+) -SI-Q209S/R456H, the enzyme activity reaches the maximum of 684U/mg, and the catalytic efficiency reaches the maximum of 22.67S -1 mM -1 Is more than 16 times of WT.
Table 2: enzymatic characterization of wild-type and different mutant sucrose isomerase
Example 5: the substrate sucrose is catalyzed to synthesize isomaltulose by using a recombinant E.coli BL21 (DE 3)/pET 28b (+) -SI-Q209S/R456H sucrose isomerase mutant.
The temperature and pH values of the original thalli and the mutant E.coli BL21 (DE 3)/pET 28b (+) -SI-Q209S/R456H are optimized. The reaction was performed at different pH (from 4.6 to 10.0) to determine its optimal pH, and the buffers used at different pH conditions were: 100mM disodium hydrogen phosphate buffer (pH 4.6-7.5), 100mM Tris-HCl buffer (pH 7.5-8.6), and 100mM Gly medium-NaOH buffer (pH 8.6-10.0). The optimum temperature of the ErSIase was also studied by measuring the enzyme activity at different temperatures (20-55 ℃).
The results showed that the optimal pH values for ErSIase_WT and ErSIase_Q209S-R456H were 6.5 and 6.0, respectively (FIGS. 3B and 3D). As shown in FIGS. 3A and 3C, both purified ErSIase_WT and ErSIase_Q209S-R456H had the highest enzymatic activity at around 40 ℃.
And finally, carrying out catalytic reaction by using whole cells under the optimal temperature and pH reaction conditions. The reaction system is 600g/L sucrose, recombinant E.coli BL21 (DE 3)/pET 28b (+) -SI-Q209S/R456H (high expression level) (0.1 g/L stem cell). Reaction conditions: constant temperature water bath 40 ℃, rotating speed 600rpm. During the whole reaction, samples (100. Mu.L) were taken at intervals of 30min, 5. Mu.L of 6M concentrated hydrochloric acid was added to terminate the reaction, and then the samples were treated, and the conversion was determined by measuring the sucrose or isomaltulose concentration using HPLC, and the reaction progress curve is shown in FIG. 4.
When the concentration of the substrate sucrose is 600g/L, the conversion rate reaches 80.0% at 60min by using 0.1g/L catalyst, and the conversion rate reaches 93.6% after the reaction is completed in 3 hours finally. Under the same reaction conditions, the conversion rate was only 74.3% after completion of the reaction for 3 hours using the initial cell (sucrose isomerase WT). Compared with wild-type sucrose isomerase, the conversion rate of the E.coli BL21 (DE 3)/pET 28b (+) -SI-Q209S/R456H sucrose isomerase mutant is improved by 19.3 percent when the mutant catalyzes 600g/L sucrose substrate.
Sequence listing
<110> Zhejiang university of industry
<120> sucrose isomerase mutant, coding gene and application thereof
<140> 2021107063374
<141> 2021-06-24
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 599
<212> PRT
<213> Unknown (Unknown)
<400> 1
Met Ser Arg Phe Thr Leu Ser Thr Val Met Ala Leu Leu Val Ala Pro
1 5 10 15
Val Leu Ser Val Leu Pro Gly Gln Val Met Ala Gly Lys Met Asp Met
20 25 30
Ala Thr Thr Gln Leu Ala Gln Lys Ser Asp Asp Phe Pro Ala Trp Trp
35 40 45
Lys Gln Ala Val Phe Tyr Gln Val Tyr Pro Arg Ser Phe Lys Asp Thr
50 55 60
Asn Gly Asp Gly Ile Gly Asp Leu Lys Gly Ile Ile Glu Lys Leu Asp
65 70 75 80
Tyr Leu Lys Arg Leu Gly Val Asp Ala Ile Trp Ile Asn Pro His Tyr
85 90 95
Asp Ser Pro Asn Thr Asp Asn Gly Tyr Asp Ile Arg Asp Tyr Arg Lys
100 105 110
Ile Met Lys Glu Tyr Gly Thr Met Glu Asp Phe Asp Arg Leu Ile Ala
115 120 125
Glu Met Asn Lys Arg Asn Met Arg Leu Met Ile Asp Ile Val Ile Asn
130 135 140
His Thr Ser Asp Gln His Ser Trp Phe Val Gln Ser Lys Gly Ser Lys
145 150 155 160
Asp Asn Pro Tyr Arg Asp Tyr Tyr Phe Trp Arg Asp Gly Lys Asn Gly
165 170 175
Gln Pro Pro Asn Asn Tyr Pro Ser Phe Phe Gly Gly Ser Ala Trp Lys
180 185 190
Lys Glu Asp Asn Ser Gly Gln Tyr Tyr Leu His Tyr Phe Ala Thr Gln
195 200 205
Ser Pro Asp Leu Asn Trp Asp Asn Pro Lys Val Arg Glu Asp Leu Tyr
210 215 220
Ala Met Leu Arg Phe Trp Leu Asp Lys Gly Val Ala Gly Leu Arg Phe
225 230 235 240
Asp Thr Val Ala Thr Tyr Ala Lys Ile Pro Gly Phe Pro Asp Leu Thr
245 250 255
Pro Gln Gln Arg Lys Asn Phe Ala Arg Thr Tyr Thr Glu Gly Pro Ser
260 265 270
Ile His Arg Tyr Ile Lys Glu Met His Gln Gln Val Phe Ser His Tyr
275 280 285
Asn Ile Ala Thr Ala Gly Glu Ile Phe Gly Val Pro Leu Glu Lys Ser
290 295 300
Ile Asp Tyr Phe Asp Arg Arg Arg Gly Glu Leu Asn Ile Ala Phe Thr
305 310 315 320
Phe Asp Leu Ile Arg Leu Asp Arg Gly Val Glu Glu Arg Trp Arg Gln
325 330 335
Lys Ala Trp Ser Leu Thr Asp Phe Arg Gln Thr Ile Asp Lys Val Asp
340 345 350
Arg Val Ala Gly Lys Tyr Gly Trp Asn Ala Phe Phe Leu Asp Asn His
355 360 365
Asp Asn Pro Arg Ala Val Ser His Phe Gly Asp Asp Arg Pro Gln Trp
370 375 380
Arg Gln Ala Ser Ala Lys Ala Leu Ala Thr Leu Met Ile Thr Gln Arg
385 390 395 400
Ala Thr Pro Phe Ile Tyr Gln Gly Ser Glu Leu Gly Met Thr Asn Tyr
405 410 415
Pro Phe Lys Ser Ile Ala Asp Phe Asp Asp Ile Glu Val Lys Gly Phe
420 425 430
Trp Gln Asp Tyr Val Ser Ser Gly Lys Val Asp Pro Glu Glu Phe Met
435 440 445
Arg Asn Val Arg Leu Thr Ser His Asp Asn Ser Arg Thr Pro Phe Gln
450 455 460
Trp Asp Glu Ser Ala Asn Ala Gly Phe Thr Ser Gly Thr Pro Trp Phe
465 470 475 480
Asn Val Asn Pro Asn Tyr Lys Leu Ile Asn Ala Ala Asp Gln Thr Arg
485 490 495
Asp Pro Asp Ser Val Phe Asn Tyr Tyr Arg Lys Leu Ile Gly Leu Arg
500 505 510
His Ala Ile Pro Ala Leu Thr Tyr Gly Glu Tyr Lys Asp Leu Asp Pro
515 520 525
Asn Asn Asp Thr Val Tyr Ala Phe Thr Arg Thr His Gly Asp Lys Arg
530 535 540
Tyr Leu Val Val Ile Asn Phe Lys Glu Asn Val Val Asn Tyr Arg Leu
545 550 555 560
Pro Asp Gln Leu Thr Ile Arg Gln Thr Leu Ser Glu Ser Ser Ala Ile
565 570 575
Gln Pro Val Ala Glu Asn Ala Arg Glu Leu Leu Leu Gln Pro Trp Gln
580 585 590
Ser Gly Ile Tyr Gln Leu Asn
595
<210> 2
<211> 1797
<212> DNA
<213> Unknown (Unknown)
<400> 2
atgtctcgtt tcaccctgtc taccgttatg gctctgctgg ttgctccggt tctgtctgtt 60
ctgccgggtc aggttatggc tggtaaaatg gacatggcta ccacccagct ggctcagaaa 120
tctgacgact tcccggcgtg gtggaaacag gcggtcttct accaggtgta cccgcgctct 180
ttcaaagaca ccaacggtga cggtatcggt gacctgaaag gtatcatcga aaaactggac 240
tacctgaaac gtctgggtgt tgacgctatc tggatcaacc cgcactacga ctctccgaac 300
accgacaacg gttacgacat ccgtgactac cgtaaaatca tgaaagaata cggtaccatg 360
gaagacttcg accgtctgat cgctgaaatg aacaaacgta acatgcgtct gatgatcgac 420
atcgttatca accacacctc tgaccagcac tcttggttcg ttcagtctaa aggttctaaa 480
gacaacccgt accgtgacta ctacttctgg cgtgacggta aaaacggtca gccgccgaac 540
aactacccgt ctttcttcgg tggttctgct tggaaaaaag aagacaactc tggtcagtac 600
tacctgcact acttcgctac ccagagtccg gacctgaact gggacaaccc gaaagttcgt 660
gaagacctgt acgctatgct gcgtttctgg ctggacaaag gtgttgctgg tctgcgtttc 720
gacaccgttg ctacctacgc taaaatcccg ggtttcccgg acctgacccc gcagcagcgt 780
aaaaacttcg ctcgtaccta caccgaaggt ccgtctatcc accgttacat caaagaaatg 840
caccagcagg ttttctctca ctacaacatc gctaccgctg gtgaaatctt cggtgttccg 900
ctggaaaaat ctatcgacta cttcgaccgt cgtcgtggtg aactgaacat cgctttcacc 960
ttcgacctga tccgtctgga ccgtggtgtt gaagaacgtt ggcgtcagaa agcttggtct 1020
ctgaccgact tccgtcagac catcgacaaa gttgaccgtg ttgctggtaa atacggttgg 1080
aacgctttct tcctggacaa ccacgacaac ccgcgtgctg tttctcactt cggtgacgac 1140
cgtccgcagt ggcgtcaggc ttctgctaaa gctctggcta ccctgatgat cacccagcgt 1200
gctaccccgt tcatctacca gggttctgaa ctgggtatga ccaactaccc gttcaaatct 1260
atcgctgact tcgacgacat cgaggttaaa ggcttctggc aggactacgt ttcttctggt 1320
aaagttgacc cggaagaatt catgcgtaac gttcgtctga cctctcatga caactctcgt 1380
accccgttcc agtgggacga atctgctaac gctggtttca cctctggtac cccgtggttc 1440
aacgttaacc cgaactacaa actgatcaac gctgctgacc agacccgtga cccggactct 1500
gttttcaact actaccgtaa actgatcggt ctgcgtcacg ctatcccggc tctgacctac 1560
ggtgaataca aagacctgga cccgaacaac gacaccgttt acgctttcac ccgtacccac 1620
ggtgacaaac gttacctggt tgttatcaac ttcaaagaaa acgttgttaa ctaccgtctg 1680
ccggaccagc tgaccatccg tcagaccctg tctgaatctt ctgctatcca gccggttgct 1740
gaaaacgctc gtgaactgct gctgcagccg tggcagtctg gtatctacca gctgaac 1797
<210> 3
<211> 39
<212> DNA
<213> Unknown (Unknown)
<400> 3
gaaggagata taccatgtct cgtttcaccc tgtctaccg 39
<210> 4
<211> 35
<212> DNA
<213> Unknown (Unknown)
<400> 4
tggtgctcga gttggttcag ctggtagata ccaga 35
<210> 5
<211> 33
<212> DNA
<213> Unknown (Unknown)
<400> 5
tacttcgcta cccagnnkcc ggacctgaac tgg 33
<210> 6
<211> 33
<212> DNA
<213> Unknown (Unknown)
<400> 6
ccagttcagg tccggmnnct gggtagcgaa gta 33
<210> 7
<211> 33
<212> DNA
<213> Unknown (Unknown)
<400> 7
gttcgtctga cctctnnkga caactctcgt acc 33
<210> 8
<211> 33
<212> DNA
<213> Unknown (Unknown)
<400> 8
ggtacgagag ttgtcmnnag aggtcagacg aac 33
Claims (7)
1. A sucrose isomerase mutant has an amino acid sequence shown in SEQ ID NO. 1.
2. A gene encoding the sucrose isomerase mutant of claim 1.
3. The coding gene according to claim 2, wherein the nucleotide sequence of the coding gene is shown in SEQ ID No. 2.
4. A recombinant vector comprising the coding gene of claim 2.
5. Use of the sucrose isomerase mutant according to claim 1 for biocatalytic sucrose preparation of isomaltulose.
6. The application of claim 5, wherein the application is: the sucrose isomerase mutant is used as a catalyst, sucrose is used as a substrate, the reaction is carried out for 3 to 12 hours under the conditions of pH of 6.0 to 7.0 and 28 to 32 ℃, and the isomaltulose is obtained in the reaction liquid.
7. The method according to claim 5, wherein the sucrose concentration in the reaction system is 500 to 600g/L.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110706337.4A CN113621601B (en) | 2021-06-24 | 2021-06-24 | Sucrose isomerase mutant, coding gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110706337.4A CN113621601B (en) | 2021-06-24 | 2021-06-24 | Sucrose isomerase mutant, coding gene and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113621601A CN113621601A (en) | 2021-11-09 |
CN113621601B true CN113621601B (en) | 2023-06-30 |
Family
ID=78378325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110706337.4A Active CN113621601B (en) | 2021-06-24 | 2021-06-24 | Sucrose isomerase mutant, coding gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113621601B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002018603A1 (en) * | 2000-08-29 | 2002-03-07 | The University Of Queensland | Isomaltulose synthase |
CN101906430A (en) * | 2010-02-02 | 2010-12-08 | 南京工业大学 | Sucrose isomerase gene and high-efficiency expression method thereof |
CN103501637A (en) * | 2011-05-05 | 2014-01-08 | 赢创工业集团股份有限公司 | Process for preparing isomaltulose from plant juices |
CN105483107A (en) * | 2015-12-31 | 2016-04-13 | 天津科技大学 | Sucrose isomerase mutant and method for producing isomaltulose |
CN112063666A (en) * | 2020-08-05 | 2020-12-11 | 浙江工业大学 | Application of recombinant sucrose isomerase in preparation of isomaltulose by converting sucrose |
-
2021
- 2021-06-24 CN CN202110706337.4A patent/CN113621601B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002018603A1 (en) * | 2000-08-29 | 2002-03-07 | The University Of Queensland | Isomaltulose synthase |
CN101906430A (en) * | 2010-02-02 | 2010-12-08 | 南京工业大学 | Sucrose isomerase gene and high-efficiency expression method thereof |
CN103501637A (en) * | 2011-05-05 | 2014-01-08 | 赢创工业集团股份有限公司 | Process for preparing isomaltulose from plant juices |
CN105483107A (en) * | 2015-12-31 | 2016-04-13 | 天津科技大学 | Sucrose isomerase mutant and method for producing isomaltulose |
CN112063666A (en) * | 2020-08-05 | 2020-12-11 | 浙江工业大学 | Application of recombinant sucrose isomerase in preparation of isomaltulose by converting sucrose |
Non-Patent Citations (2)
Title |
---|
Purification and characterization of a highly selective sucrose isomerase from Erwinia rhapontici NX-5;Ren et al.;Bioprocess Biosyst Eng;第34卷(第5期);第629-637页 * |
蔗糖异构酶突变菌株的构建及其应用研究;滕菲等;食品研究与开发;第36卷(第17期);第143-147页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113621601A (en) | 2021-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3557289B2 (en) | Recombinant thermostable enzyme that releases trehalose from non-reducing carbohydrates | |
CN110066777B (en) | Endo-inulase and application thereof in production of fructo-oligosaccharide | |
JP7241368B2 (en) | Ulva polysaccharide lyase and its coding gene and application | |
CN107532155A (en) | Truncate Pullulanase and its production method and methods for using them | |
JP3810457B2 (en) | Recombinant thermostable enzyme that converts maltose to trehalose | |
JP3557288B2 (en) | Recombinant thermostable enzyme that produces non-reducing carbohydrates with terminal trehalose structure from reducing starch sugars | |
KR100374448B1 (en) | DNA encoding enzymes, recombinant DNA (DNA) and enzymes, transformants and methods of making them | |
EP1257638A1 (en) | Bacterial isolates of the genus klebsiella, and an isomaltulose synthase gene isolated therefrom | |
CN113621601B (en) | Sucrose isomerase mutant, coding gene and application thereof | |
JP3559609B2 (en) | Recombinant enzyme, its production method and use | |
JP3557272B2 (en) | Recombinant enzyme, its production method and use | |
JP3650632B2 (en) | Recombinant enzyme that converts maltose to trehalose | |
CN113699087B (en) | Lactobacillus plantarum engineering strain for converting lactose to generate lactulose, construction method and application thereof | |
CN106119235B (en) | A kind of DPE and its application from bulkholderia cepasea | |
CN112921025B (en) | Mutant of epimerase, coding gene, amino acid sequence and application thereof | |
CN110760532B (en) | Starch branching enzyme and gene thereof, engineering bacterium containing gene and application of engineering bacterium | |
CN109439641B (en) | Application of maltogenic amylase production strain | |
CN109370973B (en) | Maltogenic amylase producing strain | |
US10465177B2 (en) | Maltooligosyl trehalose trehalohydrolase (MTHase) mutant and application thereof | |
CN112980762A (en) | Aspergillus niger disaccharide phosphorylase and application thereof in preparation of aspergillus niger disaccharide | |
KR0133727B1 (en) | Polypeptide possessing isoamylase activity andpre paration method thereof | |
CN114381446B (en) | Heat-resistant acid-resistant arabinosidase gene, and expression protein, recombinant vector, recombinant bacterium and application thereof | |
KR100637314B1 (en) | Hyperthermophilic cyclodextrin glucanotransferase from pyrococcus furiosis and production method thereof | |
CN114214304B (en) | Beta-galactosidase mutant with improved GOS conversion rate and application thereof | |
CN114015735B (en) | Method for synthesizing aspergillus niger disaccharide by cascading and catalyzing sucrose phosphorylase and glucose isomerase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240618 Address after: 450000, 9th floor, Building 3, No. 22 Cuibai Road, High tech Zone, Zhengzhou City, Henan Province Patentee after: Henan Zhongyuan Yuze Biotechnology Co.,Ltd. Country or region after: China Address before: 310014 No. 18 Chao Wang Road, Xiacheng District, Zhejiang, Hangzhou Patentee before: JIANG University OF TECHNOLOGY Country or region before: China |
|
TR01 | Transfer of patent right |